Interview
LeadersLink Kristen Dahlgren
- The organization is accelerating cancer vaccine research and building an ecosystem to facilitate the development and market entry of immune-activating treatments.
- Plans include convening the top 50 global cancer vaccine researchers at a first global cancer vaccine summit.
- Future initiatives aim to deliver cancer vaccines to market within a five to ten-year timeframe or less, while continuously working to improve treatment efficacy and reduce toxicity.
- A documentary is in production covering current scientific progress, patient hope, and identified concerns or roadblocks.
- The organization intends to maintain and expand awareness-building campaigns to ensure momentum is not lost.
- The Leaders Link program is highlighted as a critical success factor for organizational growth, with guaranteed access to mentors and thought leaders for participants.